Woodline Partners’s Day One Biopharmaceuticals DAWN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $653K | Sell |
100,516
-112,638
| -53% | -$732K | ﹤0.01% | 834 |
|
|
2025
Q1 | $1.69M | Sell |
213,154
-585,771
| -73% | -$4.65M | 0.01% | 690 |
|
|
2024
Q4 | $10.1M | Buy |
798,925
+1,592
| +0.2% | +$20.2K | 0.07% | 340 |
|
|
2024
Q3 | $11.1M | Buy |
797,333
+89,802
| +13% | +$1.25M | 0.09% | 275 |
|
|
2024
Q2 | $9.75M | Buy |
707,531
+434,993
| +160% | +$5.99M | 0.09% | 248 |
|
|
2024
Q1 | $4.5M | Hold |
272,538
| – | – | 0.04% | 369 |
|
|
2023
Q4 | $3.98M | Hold |
272,538
| – | – | 0.04% | 335 |
|
|
2023
Q3 | $3.34M | Buy |
272,538
+61,538
| +29% | +$755K | 0.04% | 352 |
|
|
2023
Q2 | $2.52M | Buy |
211,000
+59,972
| +40% | +$716K | 0.03% | 398 |
|
|
2023
Q1 | $2.02M | Hold |
151,028
| – | – | 0.03% | 421 |
|
|
2022
Q4 | $3.25M | Buy |
+151,028
| New | +$3.25M | 0.04% | 384 |
|
|
2022
Q3 | – | Sell |
-150,176
| Closed | -$2.69M | – | 768 |
|
|
2022
Q2 | $2.69M | Buy |
+150,176
| New | +$2.69M | 0.04% | 385 |
|